HDV-Like Viruses

HDV-Like Viruses

Hepatitis delta virus (HDV) is a defective human virus that lacks the ability to produce its own envelope proteins and is thus dependent on the presence of a helper virus, which provides its surface proteins to produce infectious particles. Hepatitis B virus (HBV) was so far thought to be the only h...

Full description

Bibliographic Details
Main Authors:	Jimena Pérez-Vargas, Rémi Pereira de Oliveira, Stéphanie Jacquet, Dominique Pontier, François-Loïc Cosset, Natalia Freitas
Format:	Article
Language:	English
Published:	MDPI AG 2021-06-01
Series:	Viruses
Subjects:	HDV-like viruses helper virus origin evolution
Online Access:	https://www.mdpi.com/1999-4915/13/7/1207

Similar Items

Animal delta-like viruses (Kolmioviridae: Deltavirus) and the origin of the human hepatitis D virus (HDV)
by: O. V. Isaeva, et al.
Published: (2021-11-01)

HDV Pathogenesis: Unravelling Ariadne’s Thread
by: Eirini D. Tseligka, et al.
Published: (2021-04-01)

Modeling the Interplay between HDV and HBV in Chronic HDV/HBV Patients
by: Adequate Mhlanga, et al.
Published: (2022-10-01)

Circulation of HDV Genotypes in Brazil: Identification of a Putative Novel HDV-8 Subgenotype
by: Francisco C. A. Mello, et al.
Published: (2023-06-01)

A Mathematical Model for Early HBV and -HDV Kinetics during Anti-HDV Treatment
by: Rami Zakh, et al.
Published: (2021-12-01)

IFITM3 Interacts with the HBV/HDV Receptor NTCP and Modulates Virus Entry and Infection
by: Massimo Palatini, et al.
Published: (2022-03-01)

Phylogenetic analysis of HDV isolates from HBsAg positive patients in Karachi, Pakistan
by: Perveen Shadab, et al.
Published: (2012-08-01)

Combination of Novel Therapies for HDV
by: Menashe Elazar, et al.
Published: (2022-01-01)

Seroprevalence of HBsAg, Anti-HBs, anti-HDV and HDVAg in Inonu University Medical Faculty Hospital, 2012 [Inonu Universitesi Tip Fakultesi Hastanesinde, 2012 Yilinda, HBsAg, Anti-HBs, Anti-HDV ve HDVAg Seroprevalansi]
by: Yucel Duman, et al.
Published: (2014-03-01)

Variable In Vivo Hepatitis D Virus (HDV) RNA Editing Rates According to the HDV Genotype
by: Samira Dziri, et al.
Published: (2021-08-01)

Implementation of anti-HDV reflex testing among HBsAg-positive individuals increases testing for hepatitis D
by: Adriana Palom, et al.
Published: (2022-10-01)

Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replication
by: Romina Salpini, et al.
Published: (2024-01-01)

Anti-HDV seroprevalance among patients with previous HBV infection
by: Abdurrahman Sahin, et al.
Published: (2018-06-01)

TNF-alpha inhibition ameliorates HDV-induced liver damage in a mouse model of acute severe infection
by: Carla Usai, et al.
Published: (2020-06-01)

AAV-HDV: An Attractive Platform for the In Vivo Study of HDV Biology and the Mechanism of Disease Pathogenesis
by: Sheila Maestro, et al.
Published: (2021-04-01)

HBV and HDV: New Treatments on the Horizon
by: Valentina Zuccaro, et al.
Published: (2021-09-01)

The prevalence of Co-infection with HCV and HDV in HBV infected patients in Golestan province of Iran
by: Gholamreza Roshandel, et al.
Published: (2008-01-01)

Early Multiphasic HBV Infection Initiation Kinetics Is Not Clone-Specific and Is Not Affected by Hepatitis D Virus (HDV) Infection
by: Masataka Tsuge, et al.
Published: (2019-03-01)

Systemic cytokine and viral antigen-specific responses in hepatitis D virus RNA positive versus HDV RNA negative patients
by: Shivali S. Joshi, et al.
Published: (2023-10-01)

HDV Seroprevalence in HBsAg-Positive Patients in China Occurs in Hotspots and Is Not Associated with HCV Mono-Infection
by: Imme Roggenbach, et al.
Published: (2021-09-01)

Modelling HDV kinetics under the entry inhibitor bulevirtide suggests the existence of two HDV-infected cell populations
by: Louis Shekhtman, et al.
Published: (2024-02-01)

The prevalence of HDV among HBsAg-positive populations with and without HIV-1 in China
by: Yan Wang, et al.
Published: (2024-03-01)

Seroprevalence of HDV Infection among HBsAg Positive Blood Donor in Baqubah City, Iraq
by: Linda Munjed Hadi, et al.
Published: (2018-09-01)

Seroprevalence of HDV Infection among HBsAg Positive Blood Donor in Baqubah City, Iraq
by: Linda Munjed Hadi, et al.
Published: (2018-09-01)

Prevalence of HDV infection in people living with HIV: Data from a multicenter Italian cohort
by: Laura Ambra Nicolini, et al.
Published: (2023-01-01)

The Role of Antiviral Prophylaxis in Preventing HBV and HDV Recurrence in the Setting of Liver Transplantation
by: Sara Battistella, et al.
Published: (2023-04-01)

Performance of commercially available anti-HDV enzyme-linked immunosorbent assays in Taiwan
by: Guan-Yu Lin, et al.
Published: (2020-06-01)

Management of Delta Hepatitis 45 Years after the Discovery of HDV
by: Stefano Brillanti
Published: (2022-03-01)

HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets
by: Luna Colagrossi, et al.
Published: (2018-07-01)

HBV/HDV Co-Infection: Epidemiological and Clinical Changes, Recent Knowledge and Future Challenges
by: Caterina Sagnelli, et al.
Published: (2021-02-01)

Prevalence of anti HDV in HBV carriers in Babol during 2000-02
by: MR Hassanjani Roshan, et al.
Published: (2004-01-01)

Cell Culture Systems for Studying Hepatitis B and Hepatitis D Virus Infections
by: Grace Sanghee Lee, et al.
Published: (2023-07-01)

Discontinuation of Passive Immunization Is Safe after Liver Transplantation for Combined HBV/HDV Infection
by: Ramin Raul Ossami Saidy, et al.
Published: (2021-05-01)

Identification of Novel HBV/HDV Entry Inhibitors by Pharmacophore- and QSAR-Guided Virtual Screening
by: Michael Kirstgen, et al.
Published: (2021-07-01)

Key Factors for “Fishing” NTCP as a Functional Receptor for HBV and HDV
by: Huan Yan, et al.
Published: (2023-02-01)

Successful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirin
by: Janine Hartl, et al.
Published: (2012-07-01)

Adaptive Immune Responses, Immune Escape and Immune-Mediated Pathogenesis during HDV Infection
by: Valerie Oberhardt, et al.
Published: (2022-01-01)

Deciphering the Role of Post-Translational Modifications and Cellular Location of Hepatitis Delta Virus (HDV) Antigens in HDV-Mediated Liver Damage in Mice
by: Sheila Maestro, et al.
Published: (2024-02-01)

Low prevalence of hepatitis delta infection in Cuban HBsAg carriers: Prospect for elimination
by: Licel de los Ángeles Rodríguez Lay, et al.
Published: (2023-02-01)

Prevalence and risk factors for HBV, HCV and HDV infections among injecting drug users from Rio de Janeiro, Brazil
by: M.L.A. Oliveira, et al.
Published: (1999-09-01)